Tokyo Tape
Sign in
← Cuc

Half-year report · Q2

9158.TEDINET S100UOAV
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥21.6bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥33.0bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥15.3bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥3.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥1.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥4.1bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥1.0bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥70.2bnat 2024-09-30Cons.Assets IFRS
Total assets¥62.8bnat 2024-03-31Cons.Assets IFRS
Total assets¥58.8bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥41.7bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥34.8bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥28.5bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥28.0bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥26.0bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥11.9bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥27.9bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥27.3bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥25.8bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥13.2bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥8.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥20.0bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.1bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥4.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥14.7bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥5.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥14.4bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥16.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥68.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥93.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥40.092023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥68.512024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.992023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥40.092023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio39.8%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.8%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥55m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥439m
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue2024-04-01 → 2024-09-30¥6.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue external2024-04-01 → 2024-09-30¥6.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentsegment profit2024-04-01 → 2024-09-30¥690m
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue2024-04-01 → 2024-09-30¥6.1bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue external2024-04-01 → 2024-09-30¥6.1bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentsegment profit2024-04-01 → 2024-09-30¥540m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥8.9bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥157m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.2bn
—segment totalrevenue2024-04-01 → 2024-09-30¥21.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥21.5bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥21.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥98m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥98m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥4m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥123m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥123m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥576m
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue2023-04-01 → 2023-09-30¥4.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue external2023-04-01 → 2023-09-30¥4.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentsegment profit2023-04-01 → 2023-09-30−¥50m
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentsegment profit2023-04-01 → 2023-09-30¥386m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue2023-04-01 → 2023-09-30¥5.1bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥123m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥15.4bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥15.2bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥123m
—segment totalsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥15.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥123m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 808
ItemContextValueUnit
Cash and cash equivalents IFRSPrior1QuarterInstant20004000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant13163000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember5020000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember4705000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember5522000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember15248000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember98000000JPY
Revenue from external customers IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember15346000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration15346000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember123000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember123000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Intersegment revenue IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember123000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-123000000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember5143000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember4705000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember5522000000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember15371000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember98000000JPY
Revenue IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember15469000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-123000000JPY
Revenue IFRSPrior1YTDDuration15346000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember2014000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember-50000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember386000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember2350000000JPY
Operating profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4000000JPY
Operating profit loss IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2354000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-576000000JPY
Operating profit loss IFRSPrior1YTDDuration1778000000JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_ReportableSegmentsMember－JPY
Finance income IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance income IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance income IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Finance income IFRSPrior1YTDDuration17000000JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_ReportableSegmentsMember－JPY
Finance costs IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance costs IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance costs IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Finance costs IFRSPrior1YTDDuration115000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass